Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H11N7S |
Molecular Weight | 237.285 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)NN=C1C=CC(C=C1)=NNC(N)=S
InChI
InChIKey=MLMFUKWWZIZRHX-UWRPRBHNSA-N
InChI=1S/C8H11N7S/c9-7(10)14-12-5-1-3-6(4-2-5)13-15-8(11)16/h1-4H,(H4,9,10,14)(H3,11,15,16)/b12-5-,13-6+
Molecular Formula | C8H11N7S |
Molecular Weight | 237.285 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Ambazone (1,4-benzoquinone guanylhydrazone thiosemicarbazone) is an antibacterial agent.
It exerts antitumor activity both in vitro and in vivo.
Ambazone is indicated in the treatment of infections of the mouth and throat, including tonsillitis, gingivitis, stomatitis, as well as after tonsillectomy, after tooth extraction.
Originator
Approval Year
Sample Use Guides
Faringosept (ambazone 10 mg). 3-5 tablets daily for 3-4 days. The tablets should be sucked slowly. The tablets should not be swallowed but allowed to slowly dissolve in the mouth. Use 15-30 minutes after a meal; after using the preparation, do not eat or drink fluids for 2-3 hours.
Route of Administration:
Topical
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:44:57 GMT 2023
by
admin
on
Sat Dec 16 17:44:57 GMT 2023
|
Record UNII |
BYK4592A3Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
||
|
NCI_THESAURUS |
C274
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
||
|
WHO-VATC |
QR02AA01
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
||
|
WHO-ATC |
R02AA01
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
BYK4592A3Q
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
C72627
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
m552
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB12841MIG
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
C037931
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
AMBAZONE
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
DB13697
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
539-21-9
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
100000077683
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
DTXSID3046407
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
145
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
208-713-0
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
822
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
1549158
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103762
Created by
admin on Sat Dec 16 17:44:58 GMT 2023 , Edited by admin on Sat Dec 16 17:44:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |